Schedule 13G ownership disclosure

TELOMIR PHARMACEUTICALS INC

Common Stock, no par value · CUSIP: 87975F104

Event date: 2025-09-09

Filing-level shares
1,774,900.00
Percent of class
5.50%
  • John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity

    Shares: 1,774,900.00 · Class: 5.50%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-091366
Form type
SCHEDULE 13G
Filer
DEJORIA JOHN PAUL
CIK
CIK 897610
Filed
Sep 18, 2025
Reporting period
Sep 09, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub